Genetics Generation Advancement Corp.
4160.TWO
Price:
$49.85
Market Cap:
$1.33B
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-pregnancy test, pregnancy test, newborn testing, adult health management genetic testing, adult cancer and pharmacogenetic testing, and cooperative institutes. It also provides life sciences, materials sciences, laboratory informatics, enterprise quality management system, MES, electronic delivery services. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei, Taiwan.
Industry
Medical - Diagnostics & Research
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4160.TWO
PE Ratio
[101.73]
ROE
[5.91%]
Current Ratio
[2.68]
Dividend Yield
[3.71%]
Enterprise Value
[1.26B]
Dividend History
The ROE as of December 2025 (TTM) for Genetics Generation Advancement Corp. (4160.TWO) is 5.91%
According to Genetics Generation Advancement Corp.’s latest financial reports and current stock price. The company's current ROE is 5.91%. This represents a change of 315.08% compared to the average of 1.42% of the last 4 quarters.
Genetics Generation Advancement Corp. (4160.TWO) Historical ROE (quarterly & annually)
How has 4160.TWO ROE performed in the past?
The mean historical ROE of Genetics Generation Advancement Corp. over the last ten years is 4.45%. The current 5.91% ROE has changed 33.00% with respect to the historical average. Over the past ten years (40 quarters), 4160.TWO's ROE was at its highest in in the September 2024 quarter at 3.34%. The ROE was at its lowest in in the December 2022 quarter at 0%.
Average
4.45%
Median
5.97%
Minimum
-5.03%
Maximum
9.89%
Genetics Generation Advancement Corp. (4160.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Genetics Generation Advancement Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 201.28%
Maximum Annual ROE = 9.89%
Minimum Annual Increase = -194.80%
Minimum Annual ROE = -5.03%
| Year | ROE | Change |
|---|---|---|
| 2024 | 9.89% | 48.84% |
| 2023 | 6.64% | -10.28% |
| 2022 | 7.41% | 201.28% |
| 2021 | 2.46% | -148.88% |
| 2020 | -5.03% | -194.80% |
Genetics Generation Advancement Corp. (4160.TWO) Average ROE
How has 4160.TWO ROE performed in the past?
The current ROE of Genetics Generation Advancement Corp. (4160.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.98%
5-year avg
4.27%
10-year avg
4.45%
Genetics Generation Advancement Corp. (4160.TWO) ROE vs. Peers
How is 4160.TWO’s ROE compared to its peers?
Genetics Generation Advancement Corp.’s ROE is greater than Kim Forest Enterprise Co., Ltd. (-29.27%), less than Lagis Enterprise Co., Ltd. (11.14%), less than Bioptik Technology Incorporation (7.27%), less than Perfect Medical Industry Co., Ltd. (9.28%), greater than NaviFUS Corp. (-20.73%), less than BiOptic Inc. (4.93%), greater than Acer Medical Inc. (-16.21%), greater than Enimmune corporation (-70.32%), greater than Tien Liang BioTech Co., Ltd. (-4.91%), less than GenMont Biotech Incorporation (1.18%),
| Company | ROE | Market cap |
|---|---|---|
| -29.27% | $1.15B | |
| 11.14% | $1.35B | |
| 7.27% | $1.52B | |
| 9.28% | $1.68B | |
| -20.73% | $1.47B | |
| 4.93% | $1.36B | |
| -16.21% | $1.75B | |
| -70.32% | $1.44B | |
| -4.91% | $1.39B | |
| 1.18% | $1.60B |
Build a custom stock screener for Genetics Generation Advancement Corp. (4160.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetics Generation Advancement Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Genetics Generation Advancement Corp. (4160.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Genetics Generation Advancement Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Genetics Generation Advancement Corp.'s ROE?
How is the ROE calculated for Genetics Generation Advancement Corp. (4160.TWO)?
What is the highest ROE for Genetics Generation Advancement Corp. (4160.TWO)?
What is the 3-year average ROE for Genetics Generation Advancement Corp. (4160.TWO)?
What is the 5-year average ROE for Genetics Generation Advancement Corp. (4160.TWO)?
How does the current ROE for Genetics Generation Advancement Corp. (4160.TWO) compare to its historical average?